MGMT and glioma: G-CIMP is a better predictor of glioma survival than MGMT status alone.304 As expected, a large portion of glioblastoma tumours are G-CIMP negative.305 Such hypomethylated phenotypes are likely to be directly associated with continued expression of RTK-associated oncogenes.